PHXM Annual Shareholders Equity
$25.19 M
-$679.20 K-2.63%
31 December 2022
Summary:
As of February 3, 2025, PHXM annual stockholders equity is $25.19 million, with the most recent change of -$679.20 thousand (-2.63%) on December 31, 2022. During the last 3 years, it has fallen by -$70.66 million (-73.72%).PHXM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Quarterly Shareholders Equity
N/A
30 September 2023
Summary:
PHXM quarterly stockholders equity is not available.PHXM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.6% | - |
| 3 y3 years | -73.7% | - |
| 5 y5 years | -88.4% | - |
PHXM Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -88.4% |
PHAXIAM Therapeutics SA Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $39.81 M(+58.1%) |
| Dec 2022 | $25.19 M(-2.6%) | $25.19 M(+7.5%) |
| June 2022 | - | $23.44 M(-9.4%) |
| Dec 2021 | $25.87 M(-20.8%) | $25.87 M(-40.2%) |
| June 2021 | - | $43.27 M(+32.6%) |
| Dec 2020 | $32.64 M(-65.9%) | $32.64 M(-43.2%) |
| June 2020 | - | $57.48 M(-40.0%) |
| Dec 2019 | - | $95.84 M(-15.9%) |
| Dec 2019 | $95.84 M(-42.5%) | - |
| Sept 2019 | - | $113.95 M(-14.4%) |
| June 2019 | - | $133.06 M(-20.1%) |
| Dec 2018 | - | $166.55 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $166.55 M(-23.5%) | - |
| June 2018 | - | $189.40 M(-13.0%) |
| Dec 2017 | $217.65 M(+477.7%) | $217.65 M(+117.0%) |
| June 2017 | - | $100.29 M(+166.2%) |
| Dec 2016 | $37.68 M(-26.9%) | $37.68 M(-9.9%) |
| June 2016 | - | $41.82 M(-18.8%) |
| Dec 2015 | $51.53 M(+18.3%) | $51.53 M(+49.6%) |
| June 2015 | - | $34.45 M(-20.9%) |
| Dec 2014 | $43.56 M(+132.2%) | $43.56 M(+185.6%) |
| June 2014 | - | $15.25 M(-18.7%) |
| Dec 2013 | $18.76 M(-452.3%) | $18.76 M(-18.5%) |
| June 2013 | - | $23.03 M(-532.5%) |
| Dec 2012 | -$5.33 M | -$5.33 M |
FAQ
- What is PHAXIAM Therapeutics SA annual stockholders equity?
- What is the all time high annual shareholders equity for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA annual shareholders equity year-on-year change?
- What is the all time high quarterly shareholders equity for PHAXIAM Therapeutics SA?
What is PHAXIAM Therapeutics SA annual stockholders equity?
The current annual shareholders equity of PHXM is $25.19 M
What is the all time high annual shareholders equity for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high annual stockholders equity is $217.65 M
What is PHAXIAM Therapeutics SA annual shareholders equity year-on-year change?
Over the past year, PHXM annual stockholders equity has changed by -$679.20 K (-2.63%)
What is the all time high quarterly shareholders equity for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high quarterly stockholders equity is $217.65 M